Deakin University
Browse

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

Download (805.32 kB)
Version 3 2024-06-18, 14:58
Version 2 2024-06-03, 15:03
Version 1 2018-05-02, 00:00
journal contribution
posted on 2024-06-18, 14:58 authored by J Hardy, H Skerman, P Glare, J Philip, P Hudson, G Mitchell, Peter MartinPeter Martin, O Spruyt, D Currow, P Yates
A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

History

Related Materials

  1. 1.
    DOI - Is version of https://doi.org/10.1186/s12885-018-4404-8

Location

England

Open access

  • Yes

Link to full text

Language

English

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2018, The Authors

Journal

BMC Cancer

Volume

18

Article number

ARTN 510

ISSN

1471-2407

eISSN

1471-2407

Issue

1

Publisher

BIOMED CENTRAL LTD

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncologyNauseaVomitingPalliative careAntiemeticGuidelinesFAR-ADVANCED CANCERQUALITY-OF-LIFEMANAGEMENTHALOPERIDOLEFFICACY3211 Oncology and carcinogenesis

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC